Elucida Oncology Revenue and Competitors

Monmouth Junction, NJ USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Elucida Oncology's estimated annual revenue is currently $3.7M per year.(i)
  • Elucida Oncology's estimated revenue per employee is $155,000

Employee Data

  • Elucida Oncology has 24 Employees.(i)
  • Elucida Oncology grew their employee count by -25% last year.

Elucida Oncology's People

NameTitleEmail/Phone
1
Chief Medical OfficerReveal Email/Phone
2
VPReveal Email/Phone
3
Head Materials AnalysisReveal Email/Phone
4
VP, Technology and CMCReveal Email/Phone
5
VPReveal Email/Phone
6
Head Formulation Development, C’ Dot-Drug-ConjugateReveal Email/Phone
7
Chief Medical OfficerReveal Email/Phone
8
Associate Director Preclinical ResearchReveal Email/Phone
9
Executive Director, Program Management and Principal ConsultantReveal Email/Phone
10
Chief Scientific OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.5M55-21%N/AN/A
#2
$0.2M10%N/AN/A
#3
$8.5M55-29%N/AN/A
#4
$108.5M5002%N/AN/A
#5
$0.8M50%N/AN/A
#6
$0.6M40%N/AN/A
#7
$14.7M68-23%$206.4MN/A
#8
$492.2M1503-15%$568MN/A
#9
$1.1M7-42%N/AN/A
#10
$4.5M290%N/AN/A
Add Company

What Is Elucida Oncology?

Elucida Oncology, Inc., is a clinical development stage company based on proprietary ultra-small C-Dot technology to find, see and treat an array of solid tumor cancers. Developed and clinically translated by Memorial Sloan-Kettering Cancer Center and Cornell University, C-Dots have published human safety and tumor-specific clinical data. Elucida Oncology is currently progressing through a broad clinical trial program while continuing to drive a future portfolio through ongoing innovation.

keywords:N/A

N/A

Total Funding

24

Number of Employees

$3.7M

Revenue (est)

-25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Elucida Oncology News

2022-04-06 - Elucida Oncology's Lead Clinical Candidate ELU001 to Be ...

MONMOUTH JUNCTION, N.J., April 04, 2022 (GLOBE NEWSWIRE) -- Elucida Oncology, a clinical-stage biotechnology company developing the next...

2022-03-22 - Elucida Oncology to Present at Two Upcoming Scientific ...

Elucida Oncology, Inc., is a clinical-stage biotechnology company pioneering the next frontier in targeted cancer therapy with its first-in-...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.7M244%N/A
#2
$2.5M25N/AN/A
#3
$4M26-10%N/A
#4
$2.2M2686%N/A
#5
$4.2M270%N/A